Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Keywords: Inflammation Atherosclerosis Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 99
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate whether rosuvastatin improves measures of endothelial function, decreases measures of inflammation, and improves pulmonary function in patients with stable chronic obstructive pulmonary disease.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Rosuvastatin intervention 2: Placebo
Intervention descriptions: intervention 1: 10mg tablets, once daily in three months intervention 2: 1 tablet, once daily in three months

Protocol document: